DiscoverThe Lattice (Official 3DHEALS Podcast)
The Lattice (Official 3DHEALS Podcast)
Claim Ownership

The Lattice (Official 3DHEALS Podcast)

Author: 3DHEALS

Subscribed: 1Played: 17
Share

Description

Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule breakers, and more focusing on how we can use 3D technologies, like 3D printing and bioprinting to reinvent healthcare and even life sciences. This podcast will also include AMA (Ask Me Anything) sessions, past Instagram Live interviews, and other direct engagements with our Tribe. Be sure to follow us on Facebook, Twitter, and Instagram @3dheals and check out the links in show notes.
38 Episodes
Reverse
This is the audio recording of a recent IG Live interview with co-founder of Anatomiz3D, an Indian medical 3D printing startup focusing on a variety of medical applications using 3D printing. Anatomiz3D is also the trailblazer on delivering point of care 3D printing service in Indian hospitals. In this interview, Firoza shared with us a few fun projects she did with surgeons (video available), and also gave us a tour of her office. By the way, this was no ordinary "office".  For those who want to watch the video, you can find it on our IGTV (@3dheals) or this link: https://3dheals.com/3dheals-instagram-live-medical-3d-printing-with-co-founder-of-anatomiz3d-firoza-kothariAbout the Speaker: Firoza Kothari, Co-Founder & CTO – Anatomiz3D Medtech Pvt. Ltd. – A B.Tech in Biotechnology Engineering, Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 700 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India and are pioneers for the same.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This is the audio recording of a recent 3DHEALS IG Live session.  We had the pleasure to interview Dr. Mayra Vasques, founder of Innov3D. She is also an educator and a passionate technologist for the adoption of dental 3D printing. In this episode, we focused on an application that inspired her journey: a 3D printed nightguard. This was also relevant to her Ph.D. thesis. We also answered live audience questions, including how the adoption of 3D printing differs between small and large dental labs. Dr. Vasques reveals some facts not commonly known to the public. Guest Speaker Bio: Dr. Mayra Vasques is the founder of iNNOV3D an EdTech company focused on supporting and training teachers and universities in Healthcare for the innovative and efficient use of 3D Technologies. The company was founded based on the belief that the best innovative solutions in healthcare will emerge from professionals that are raised familiar with technology and for this, the institutions must be prepared for these professionals.She started in the additive manufacturing field in 2015, during her Ph.D. Fellow at School of Dentistry at the University of Sao Paulo, where she led a project in additive manufacturing for the development of occlusal splints for patients with orofacial pain. Since then she has been involved in several AM research projects and as a panelist in conferences.She is deeply involved in creating a positive and more accessible local ecosystem in Brazil for digital technology and AM, working for local community building associated with international organizations such as ”Women in 3D Printing” and “3DHeals”.The video format of the show and relevant info can be found in the following link: 3DHEALS Instagram Live Recording: Dental 3D Printing with Innov3D Founder Dr. Mayra VasquesSupport the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
What is the Australian and Melbourne healthcare 3D Printing/ Bioprinting ecosystem like? Look no further than our Melbourne community manager William Harley, who not only has been keeping a close eye on local trends and happenings but also has a deep understanding of the scientific aspects of the development. In this episode, we learned a little about Bill's research on acoustic assisted bioprinting, local leaders on the commercial side of healthcare 3D printing, and major funding entities. Of course, we also highlighted the upcoming Melbourne virtual event and How he picked speakers for this event. (Free event, almost sold out.) During the live Q&A session, we talked a little about getting a Ph.D. and being a scientist. Speaker Bios:William HarleyWilliam Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.Jenny Chen, M.D.3DHEALS Founder/CEOJenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.Relevant links to this episode:Bioprinting for Tissue Engineering and Regenerative Medicine in Australia: 2020 Workshop HighlightsAustralian Regulatory Updates for 3D Printed Medical Devices and Implants3D Med 19 Conference (Australia) RecapBioprinting Down Under (Australia): Recent Workshop Take-awaySupport the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Richard Doerer, founder of Modl3DVet, also a 25 year veteran in 3D printing shared his recent works and vision for the future veterinary 3D printing market with Jenny Chen.  Ranging from anatomical surgical model, military/police dog training device, to educational tools, Richard showed us a new burgeoning market that has been accelerated since the pandemic. Many questions are still unanswered, and he highlighted the importance of the upcoming 3DHEALS March virtual event: https://3dheals.com/3d-printing-in-veterinary-practice (Registration to this live webinar is free by the way).Other important links: https://3dheals.com/3dheals-live (future 3DHEALS IG Live event)https://3dheals.com/guide-together-into-2021-connected-while-decentralized (our event and media guide for 2021)About Our Speakers: Richard Doerer3DHEALS Detroit Community Manager, Founder Modl3d, LLC Royal Oak, MIRichard Doerer is the 3DHEALS Detroit Community Manager. He is the founder of Modl3D, LLC, a medical technology company specializing in 3D printing and medical imagery for veterinary practices and education. Recent projects include canine nasal sarcomas, brain meningiomas, and aneurysms in the caudal vena cava. He started with additive in the 1990’s using 3D Systems SLA’s for product development for consumer goods. Richard has been involved in product development in consumer products and automotive for the past 25 years. In addition to his work with Modl3D, Richard is the Additive Lab Manager/Engineering Manager for Adient, LLC. Adient, LLC is the largest global automotive seat manufacturer.  Richard is a graduate of the Yale School of Art MFA and Michigan State University MBA.Jenny Chen, M.D.3DHEALS Founder/CEOJenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.More about this session: https://3dheals.com/3dheals-ig-live-recordings-3d-printing-in-veterinary-medicine-with-richard-doererSupport the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This is a recording of our recent Instagram Live session with Fabio Sant’Ana, focusing on metal 3D printing implants, the importance of feedstock, and what are the major differences in applications between Electron Beam Melting (EBM) and Selective Laser Melting (SLM) 3D printer. This conversation was inspired by his recent Expert Corner blog. During the live audience Q&A, we also answered questions related to anatomical modeling both in the U.S. and Brazillian market.Fabio Sant’Ana has a Precision Mechanics degree and a Business Administration Bachelor’s, born and raised in São Paulo he has 25 years of experience in helping companies to acquire and take full advantage of 3d Machining and Additive Manufacturing Equipment. Entrepreneur and knowledge avid is a member of standards organizations ASTM F42 Additive Manufacturing, ABNT CEE-261 Manufatura Aditiva e ABNT CB-26 Odonto-Médico-Hospitalar. CAD/CAM, Surface Modelling, and EBM specialist is passionate in connect people and companies to the right tools to accomplish the mission. You can follow Fabio on Instagram @farccotecnologia.https://3dheals.com/metal-3d-printing-implants-with-fabio-santana-instagram-live-recording-show-notesSupport the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A fun but insightful conversation during 3DHEALS2020 with two inspiring entrepreneurs in 3D Bioprinting space, Tamer Mohamed (CEO and co-founder of Aspect Biosystems), and Mike Graffeo (CEO and co-founder of Fluidform). Aspect bio has just successfully completed its series A round, and Fluidform just successfully raised its seed round. Learn from Tamer and Mike on what startup CEOs' challenges, experiences, visions, and advice for the biofabrication and 3D printing space. Full conference video recording can be purchased here. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Allevi (previously known as Biobots) was one of the earliest companies focusing on bioprinting for pharma research and organ regeneration. We are fortunate to have a fun and insightful 20-minute ice breaker style interview with its co-founder and CEO Ricky Solorzano, starting from how Ricky got introduced into the RepRap movement, how he crossed paths with several great minds in the field throughout his scientific and entrepreneurship journey, where Allevi is as a company, and how he and his team is coping with the pandemic. Ricky will be speaking at the 3D Printing in Space panel at the upcoming 3DHEALS2020. His complete more in-depth written interview can be found here. Ricky Solorzano, Co-Founder, and CEO of Allevi – Ricky guides the vision, strategy, and day to day of the company. He has been obsessed with tissue engineering for 10 years, studied Bioengineering at the University of Pennsylvania, and created the world’s first desktop 3D bioprinter out of his dorm room. He has been influential in creating the biofabrication industry and has been a Forbes 30 under 30, Inc 30 under 30, and Business Insider 100: The Creators #65. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Have a complex spine problem? Mike Cordonnier from Carlsmed may have an answer for you. While orthopedic surgeons are no strangers to virtual pre-operative surgical planning, it is a different challenge to also provide a patient-specific implant to fit into the patient, rather than molding patient to fit the device. In this interview with our upcoming 3DHEALS2020 speaker, Mike and I discussed how his company aims to realize medical imaging to patient-specific surgical plan and device, leveraging AI, cloud computing, data, and additive manufacturing (or 3D printing). We also touched upon how the ongoing COVID19 pandemic will change the future of surgery. Mike Cordonnier is CEO and co-founder of Carlsmed, a San Diego based Med Tech company. Carlsmed’s Corra system utilizes predictive analytics to create patient-specific surgical plans and 3d printed implants to improve patient outcomes for spine surgery.  Mike has held various leadership roles for large MedTech companies NuVasive, Zimmer Biomet, and Orchid Orthopedics as well as early-stage startups Ellipse Technologies and X-Spine Systems.  Mike is passionate about leveraging technology to improve patient outcomes and decrease the cost of healthcare.  Mike has a B.S. in Mechanical Engineering from the University of Dayton. Mike will be a speaker for 3DHEALS2020 Orthopedic Panel.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
3DHEALS2020 Dental Ambassador Dr. Nabeel Cajee did a quick ice-breaker style interview with Dr. Devic Zille, Director of Applied Innovations at OsteoMed. How can 3D Printing make oral surgeons' lives easier using well-designed 3D printed solutions? Previously an oral surgeon himself, Dr. Zille is working on incorporating 3D printing as a part of a virtual surgical planning solution. Dr. Devid Zille leads the Patient-Specific Implant initiative for Osteomed, one of the world’s largest small-bone implant manufacturers, dealing with Maxillofacial, Neuro, and Extremities surgery. He is post-graduate in Oral and Maxillofacial Surgery mainly focused on the correction of facial deformities. His expertise includes 3D modeling and design using advanced concepts like lightweight structures and topological optimization based on FEA analysis and 3D printing. Dr. Zille will be speaking on the 3D Printing for CMF panel in the upcoming 3DHEALS2020. He also authored an Expert Corner blog for 3DHEALS.com previously here. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In the midst of the COVID-19 pandemic, we are fortunate to have a few minutes to interview Dr. Chaw Sing Ho, co-founder and managing director of NAMIC (National Additive Manufacturing Innovation Cluster) of Singapore, which is an organization comparable to America Makes in the United States. This ice-breaker style interview explores Dr. Ho's personal journey to co-founding NAMIC; what drives him behind his work with NAMIC, and how NAMIC works to accelerate adoption and innovation in 3D printing in Singapore, in alignment with Singaporean economic development, as well as how NAMIC is doing to mitigate supply chain crisis in this pandemic. The interview also briefly touches upon resources available to 3D Printing startups (either internal or external to Singapore) from NAMIC. Guest Biography: Chaw Sing Ho is the co-founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government initiative to catalyze innovation and scale industrial adoption of additive manufacturing technologies. By focusing on industrial applications and translational R&D, together with commercial strategies to co-create innovative products and services, the national initiative aims to position Singapore as one of the leading digital manufacturing hubs in the era of digitalization and smart factories. Since its inception two years ago, NAMIC has raised more than $24 million in public-private funding to support various AM initiatives across industry verticals.Prior to NAMIC, he oversaw IP Innovation Strategic Partnerships at HP Singapore. Before that, he was the global head of manufacturing supply chain operations and product innovation for the consumer inkjet supplies business in HP. Chaw Sing started his career in the semiconductor industry with Chartered Semiconductor and Globalfoundries, where he undertook various leadership and customer-facing roles in technology development and engineering operations.Chaw Sing holds a doctorate in Electrical and Computer Engineering and a Bachelor’s (honors) degree in Electrical Engineering majoring in Microelectronics from the National University of Singapore (NUS). He is an avid inventor with several US/international patents. An advocate for 3D Printing and its role in the new economy, he has spoken in various forums and workshops. He mentors a number of start-ups in the digital and healthcare space. He sits on a number of advisory and expert committees and is an appointed mentor under the GE Digital ASEAN Startup and Partner Program. He is personally interested in nurturing deep tech start-ups, as well as advancing STEM education and engineering as a profession. In his free time, he enjoys sports, movies, reading, and spending time with his family.  Dr. Chaw Sing Ho will be a speaker at 3DHEALS2020. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A lot of us started our journey in healthcare 3D printing accidentally. Listen to this ice-breaker style interview with Dr. Shafkat Anwar, Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). Hear his story on how 3D+ Technologies beyond 3D printing is helping patients (and their families) fighting against congenital heart disease and how UCSF 3D+ Lab is combating against the ongoing pandemic. His full written interview can be found here.   He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020.Dr. Shafkat Anwar (Twitter: @ShafkatAnwar) is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI). He is the Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). He is a founding member and the inaugural Chair of the Advanced 3D+ Visualization Special Interest Group in the Society for Cardiovascular Magnetic Resonance. He is a consultant at Printerprezz, a medical start-up in Fremont, CA utilizing additive and other advanced manufacturing technologies to develop the next generation of medical devices.  At Printerprezz. Dr. Anwar serves as the Senior Vice President of Medical Innovations. Dr. Anwar completed his internship and residency in Pediatrics at Children’s National Medical Center, as well as a research fellowship at the National Institutes of Health. He completed fellowships in Pediatric Cardiology and Cardiac Imaging at Cleveland Clinic and Children’s Hospital of Philadelphia. Prior to joining UCSF, Dr. Anwar was the Cardiology Director of Cardiac MRI at Washington University in St. Louis, St. Louis Children’s Hospital.  At Wash. U. Dr. Anwar co-founded and co-directed the Center for 3D Printing, a multi-disciplinary 3D printing center. He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
We are fortunate to have Steve Kranz, a senior material scientist at Origin to chat about his life journey as a material scientist for 3D printing, what is an Open Additive Production system, how Origin pivoted in this pandemic and his various hobbies outside of work, including his life long interest in being a storyteller, and a recent publication of a memoir of a prisoner ( "Archie: Gold in the Fire" ). Steve will be a speaker at the material science panel at 3DHEALS2020 in June 2020. The rest of Steve's more in-depth written interview can be found here. Guest Biography: Steve Kranz has been the senior scientist and lab manager at Origin since 2017. Before joining Origin, he worked on the Autodesk Ember 3D Print team in 2016. From 2013-2015, he worked with Prof. William Hammack to write, edit and produce educational engineering videos for the EngineerGuy Youtube channel. In 2013, he graduated from the University of Illinois at Urbana-Champaign with an MS in Materials Science and Engineering.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this ice-breaker style interview, upcoming 3DHEALS2020 speaker Dr. Gustavo Mendonça shared with us (Dr. Cajee) on where digital dentistry and dental 3D printing are in restorative dentistry and in the future of dental education. The two also briefly discussed the potentially important role bioprinting and biofabrication can play in restorative dentistry. See full written, video, podcast version of this interview here. Dr. Gustavo Mendonça received his DDS in 1999 from the University of Uberlândia – School of Dentistry, Brazil. He also completed his postgraduate training in Prosthodontics and a Masters Degree in Oral Rehabilitation from the same school in 2003. In 2008 he finished his Ph.D. in Genomic Sciences and Biotechnology at the Catholic University of Brasília, Brazil. Dr. Mendonça was an Assistant Professor in the Department of Prosthodontics at Catholic University of Brasília – School of Dentistry with an extra-mural private practice from 2003-2007. From 2008 to 2010 he completed post-doctoral research training at UNC-Department of Prosthodontics in the Bone and Mineralization Laboratory. Dr. Mendonça currently teaches in the Comprehensive Care VIC Clinics and the fixed and removable prosthodontics preclinical courses. Dr. Mendonça’s current research interests include the effect of nano- and micro-topography on osteoblast behavior, mesenchymal stem cell differentiation into osteoblasts and the molecular basis of dental implants osseointegration. Clinical research interests include replacing missing teeth with dental implants, evaluating the longevity of implant treatment and CAD/CAM restorations. Dr. Gustavo Mendonça will be speaking at the upcoming 3DHEALS2020, June 5th-6h, 2020, along with other 40+ world-class speakers.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Mike Vasquez is a 3D Printing expert specializing in pushing the boundaries of advanced 3D printing technology. He is the Founder and CEO of 3Degrees, a Chicago-based consulting company focused on helping organizations maximize their investment in the technology. Over the past decade, he has worked side-by-side with some of the top machine manufacturers, material producers and end-users in the industry, consulting with them to identify novel applications, test new materials, and develop frameworks to maximize R&D efficiency and boost ROI. In the past 18 months, Mike has worked with a dozen companies to help them set up successful and safe facilities. He has also created a software tool called TRACE. It aims to assist companies formalizing their use of 3D Printing to ensure they can meet quality and technical standards outlined by their supply chain and industry requirements. He completed his Ph.D. in Additive Manufacturing at Loughborough University and received both his Bachelors's and Masters from MIT in Materials Science and Engineering.Mike will be speaking on the material science panel at 3DHEALS2020. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, we are fortunate to have a few minutes with Dr. Albert Woo (in between surgeries) to learn more about his journey in 3D printing as a plastic surgeon and how he was able to work with healthcare organizations and find resources for his innovative work in the space, not just in plastic surgery but other specialties as well. Albert will be speaking on the CMF panel during 3DHEALS2020 virtually in June.  Full written, video, audio interviews can be found here. Albert S. Woo, FACS is a board-certified plastic and reconstructive surgeon who specializes in the treatment of cleft and craniofacial anomalies. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and Director of the new Lifespan 3D Printing Laboratory.Besides medical 3D printing, Dr. Woo’s clinical interests include the surgical treatment of patients with craniosynostosis, complex and syndromic craniofacial abnormalities, and cleft deformities. In particular, he is internationally recognized as an expert in cleft palate repair, after having developed a new surgical technique for this procedure. He is also a nationally recognized for his expertise in Endoscopic Craniosynostosis Surgery, with numerous papers and national presentations on the subject. With more than 60 peer-reviewed publications, numerous chapters and a book, Dr. Woo remains committed not only to clinical excellence but also to advancing research in the treatment of craniofacial anomalies.Dr. Woo currently is a member of numerous societies including the American College of Surgeons, the American Society of Maxillofacial Surgeons, the American Cleft Palate-Craniofacial Association, the American Association of Plastic Surgeons, and the American Society of Plastic Surgeons. He is the recipient of numerous awards, including recognition by Best Doctors in America since 2011 and Castle Connolly’s Top Doctors. Dr. Woo recently co-founded a startup, Implant3D.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Today I had the opportunity to interview upcoming 3DHEALS2020 speaker, Roger Kuan, an intellectual property attorney who specializes in 3D printed medical devices and bioprinting innovations. Roger shared his perspectives on how a startup should approach legal help, what COVID19 could impact IP law and startups in the healthcare and other pearls of wisdom. Roger's more in-depth written interview can be also found here. Roger Kuan is a partner with McDermott Will & Emery and he focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus on emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks, and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A short interview with 3DHEALS2020 bioprinting panel speaker, Jordan Miller, co-Founder and CEO of Volumetric, and Professor at Rice University. Volumetric's light-based bioprinting platform was featured on the cover Science last year. In this episode, Jordan shared what motivated him to tackle tough problems like organogenesis for transplant, his perspective on how biology, art/design, and 3D printing have always worked together in the field of tissue engineering, his thoughts on how his background and vascularization projects can help the COVID19 pandemic, plus his late experience as a graduate of YC Class 2020. Full written interview is here. Jordan Miller is an Assistant Professor of Bioengineering at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo. Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
3DHEALS Dental Ambassador Dr. Nabeel Cajee interviews Judith Thomas, who currently leads the dental 3D printing efforts at Origin, an SF 3D printing startup. Judy shared with us her experience with digital dentistry in the past 20+ years, how she got into 3D printing (surprise!), and what she and Origin are working on during the COVID19 pandemic. Judy will be part of the Dental 3D Printing panel in the upcoming 3DHEALS2020, global healthcare 3D Printing Summit. Guest Biography: Judith Thomas-Account Executive for Origin. Origin is a manufacturer of an open platform solution for additive manufacturing. Judith has represented leading companies such as 3M and Carbon in serving the dental market for 20 years. Her expertise includes both clinical and manufacturing applications related to a broad range of dental applications utilizing advanced materials and technology including nano-technology, zirconia, cad/cam, lasers, implant dentistry, and additive manufacturing. Dentistry has been her passion as she has been able to work with cutting edge materials and manufacturers directly impacting both dental professionals and patients. Technology and materials should provide solutions which, minimize complexity and enhance our world.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Check out this informative interview between Dr. Mayasari Lim (Roosterbio/3DHEALS) and Adam Feinberg, Professor at Carnegie Mellon University, CTO and co-founder at FluidForm. Learn how Adam first got into 3D printing and bioprinting (years ago!), and how his team at CMU discovered the FRESH technique. Adam also shared his view on how to stay critical of convention and learn to think outside of the box. Adam will be speaking at the Organogenesis/Bioprinting panel at 3DHEALS2020 in June 2020. Guest Biography: Dr. Adam Feinberg is CTO and co-founder of FluidForm. The core technology of FRESH printing was developed in his Regenerative Biomaterials and Therapeutics lab at Carnegie Mellon University (CMU), where he is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering. His group develops materials-based, engineering strategies to control the self-organization and assembly of various cell types into tissues. Adam earned his Bachelor of Science in Materials Science and Engineering from Cornell University, and his MS and PhD in Biomedical Engineering from the University of Florida. He performed his postdoctoral work at the School of Engineering and Applied Science at Harvard University. He holds more than 20 US patents and patent applications, has authored over 45 publications, and is a member of the Materials Research Society, American Chemical Society, Society for Biomaterials, Biophysical Society, Biomedical Engineering Society, and the American Heart Association.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O'Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. More specifically, Xylyx aims to translate the cell-specific extracellular matrix into biomaterial products with real-world impact. In this short interview, John shared with us his story of co-founding Xylyx, his vision for the future of bioprinting and tissue engineering, and lessons he learned from past successes and failures. John will be speaking with other startup founders and scientists on the Biofabrication Ecosystem panel on June 6th, 2020 at 3DHEALS2020. Guest Biography: Dr. John O’Neill is an expert on biomaterials and tissue- and disease-specific models aimed at transforming drug discovery. He has published extensively in the areas of extracellular matrix  (ECM), stem cell research, cell and tissue engineering, regenerative medicine, whole organ recovery and bioengineering, and the use of biomaterials in research, drug discovery and clinical applications. He is an inventor/co-inventor on over 10 issued and pending patents in biotechnology and imaging systems. Dr. O’Neill developed Xylyx Bio’s proprietary platform technology while completing his Ph.D. in Biomedical Engineering at Columbia University in the Laboratory for Stem Cells and Tissue Engineering under Gordana Vunjak-Novakovic, a world leader in tissue engineering, with expertise in regenerative medicine, translational stem cell applications, and disease modeling.Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
loading
Comments 
Download from Google Play
Download from App Store